Application

18436589 · USE OF SUBLINGUAL DEXMEDETOMIDINE FOR THE TREATMENT OF AGITATION

Filed 2024-02-08 · Abandoned The official file ↗ · Art unit 1612 · Examiner Frederick F Krass Hard · CPC A61K 31/4174 · BioXcel Therapeutics, Inc. · COOLEY LLP / BioXcel Therapeutics

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

3.7 mo

to disposition 12.1 mo

Statutes raised

103 112 DP

1 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.